Stocks360

Cognizant Technology Solutions Corporation (CTSH)

Stock analysis · NASDAQ · Technology · Information Technology Services

Share: Facebook X WhatsApp SMS
$66.22

Get deeper signals and personalized alerts

Free account signup in under 60 seconds

Create free account → I already have an account
Market Cap
$29.83B
PE (TTM)
14.21
EPS (TTM)
N/A
Dividend Yield
1.96%
Beta
0.85
Day Range
$65.77 – $68.56
52-wk Range
$37.08 – $87.03
Avg Volume
N/A
Volume
10.88M

Cognizant Technology Solutions Corporation (CTSH) is a publicly traded company in the Technology sector. Latest price: $66.22. Market cap $29.83B. Trailing PE 14.21. Dividend yield 1.96%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

1-Year Price

2025-10-28 · $67.82 2026-10-27 · $66.22 (-2.36%)

Earnings

Most Recent
Jul 29, 2026
EPS $1.37 vs est. $1.38
Missed by $0.01
Next Earnings
Oct 29, 2026
EPS estimate $1.46

Proprietary Signals

Signal snapshot temporarily unavailable.

About Cognizant Technology Solutions Corporation

Cognizant Technology Solutions Corporation functions as a global professional services firm, delivering a comprehensive suite of consulting, technology, and outsourcing solutions across North America, Europe, and other international markets. Its operations are structured into four primary divisions: Financial Services, Healthcare, Products and Resources, and Communications, Media and Technology. Within the Financial Services sector, Cognizant provides advanced services such as enhancing customer experiences, implementing robotic process automation (RPA), and leveraging analytics and artificial intelligence (AI) to address needs in areas like digital lending, fraud prevention, and modern payment systems. For its Healthcare clients, the company focuses on navigating industry shifts toward consumer-centric models, outcome-based agreements, and digital health initiatives, striving to deliver an integrated, seamless, and patient-focused omnichannel experience. Furthermore, Cognizant assists in optimizing operations across various functions, including clinical development, pharmacovigilance, manufacturing, claims management, enrollment procedures, membership administration, and billing…

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)14.21×
P/S (TTM)1.38×
P/B2.13×
P/FCF (TTM)11.48×
EV / EBITDA7.52×
EV / Sales1.43×
Earnings Yield7.19%
Free Cash Flow Yield8.71%
Dividend Yield1.96%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value$30.88B
Revenue (TTM)$21.64B
Net Income (TTM)$2.15B
Free Cash Flow (TTM)$2.62B
Net Debt$1.06B
Working Capital$4.09B
Gross Margin32.00%
Operating Margin15.76%
Net Margin10.26%
Return on Equity14.94%
Return on Invested Capital12.32%

Peers

Recent News

Related

Browse more tickers: sitemap